Unknown

Dataset Information

0

Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial.


ABSTRACT: The Women's Health Study trial previously reported no overall effect of low-dose aspirin (100 mg every other day) on invasive breast cancer over an average of 10 years of treatment. The present subgroup analyses further show no effects by tumour characteristics at diagnosis, suggesting that low-dose aspirin has no preventive effect on breast cancer.

SUBMITTER: Zhang SM 

PROVIDER: S-EPMC2266841 | biostudies-literature | 2008 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial.

Zhang S M SM   Cook N R NR   Manson J E JE   Lee I-M IM   Buring J E JE  

British journal of cancer 20080212 5


The Women's Health Study trial previously reported no overall effect of low-dose aspirin (100 mg every other day) on invasive breast cancer over an average of 10 years of treatment. The present subgroup analyses further show no effects by tumour characteristics at diagnosis, suggesting that low-dose aspirin has no preventive effect on breast cancer. ...[more]

Similar Datasets

| S-EPMC4181666 | biostudies-literature
| S-EPMC3821875 | biostudies-literature
| S-EPMC7722096 | biostudies-literature
| S-EPMC5969345 | biostudies-literature
| S-EPMC1479833 | biostudies-literature
| S-EPMC5701114 | biostudies-literature
| S-EPMC3790151 | biostudies-literature
| S-EPMC6152923 | biostudies-literature
| S-EPMC6287899 | biostudies-literature
| S-EPMC6067363 | biostudies-literature